During the past decade, San Juan Community Oncology Group conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 2 clinical trials were completed, i.e. on average, 7.4% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "San Juan Community Oncology Group" #1 sponsor was "National Cancer Institute (NCI)" with 18 trials, followed by "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored, "Alliance for Clinical Trials in Oncology" with 5 trials sponsored, "SWOG Cancer Research Network" with 4 trials sponsored and "NRG Oncology" with 4 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "San Juan Community Oncology Group" #1 collaborator was "National Cancer Institute (NCI)" with 16 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Division of Cancer Control" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "San Juan Community Oncology Group" are "Invasive Breast Carcinoma" (3 trials), "Plasma Cell Myeloma" (3 trials), "Recurrent Breast Carcinoma" (3 trials), "Recurrent Ovarian Carcinoma" (3 trials) and "Breast Carcinoma" (2 trials). Many other conditions were trialed in "San Juan Community Oncology Group" in a lesser frequency.

Most popular intervention types in "San Juan Community Oncology Group" are "Drug" (26 trials), "Other" (23 trials), "Procedure" (15 trials), "Biological" (13 trials) and "Radiation" (8 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (13 trials), "Biospecimen Collection" (8 trials), "Quality-of-Life Assessment" (8 trials), "Computed Tomography" (7 trials) and "Pembrolizumab" (6 trials). Other intervention names were less common.

The vast majority of trials in "San Juan Community Oncology Group" are 24 trials for "All" genders, 8 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "San Juan Community Oncology Group". undefined are not yet recruiting, 10 are recruiting, 23 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in San Juan Community Oncology Group, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in San Juan Community Oncology Group, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".